The store will not work correctly when cookies are disabled.
Glabrisoflavone
ID: ALA1086439
PubChem CID: 5378945
Max Phase: Preclinical
Molecular Formula: C20H18O6
Molecular Weight: 354.36
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Synonyms: Glabrisoflavone | Hydroxywighteone|5,7,4'-Trihydroxy-6-(3-hydroxymethyl-2-butenyl)isoflavone|Glabrisoflavone|CHEMBL1086439|AROTXIUFXQZGLT-BIIKFXOESA-N|LMPK12050195|5,7-dihydroxy-6-[(E)-4-hydroxy-3-methylbut-2-enyl]-3-(4-hydroxyphenyl)chromen-4-one|5,7,4'-Trihydroxy-6-[3-(hydroxymethyl)but-2-enyl]isoflavone|(e)-5,7,4'-trihydroxy-6-(3-hydroxymethyl-2-butenyl)isoflavone|5,7-Dihydroxy-6-[4-hydroxy-3-methyl-2-butenyl]-3-(4-hydroxyphenyl)-4H-chromen-4-one
Canonical SMILES: C/C(=C\Cc1c(O)cc2occ(-c3ccc(O)cc3)c(=O)c2c1O)CO
Standard InChI: InChI=1S/C20H18O6/c1-11(9-21)2-7-14-16(23)8-17-18(19(14)24)20(25)15(10-26-17)12-3-5-13(22)6-4-12/h2-6,8,10,21-24H,7,9H2,1H3/b11-2+
Standard InChI Key: AROTXIUFXQZGLT-BIIKFXOESA-N
Molfile:
RDKit 2D
26 28 0 0 0 0 0 0 0 0999 V2000
4.8996 -6.0033 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.8983 -6.8308 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.6113 -7.2436 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.6093 -5.5905 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.3274 -5.9993 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.3264 -6.8328 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.0439 -7.2481 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.7668 -6.8344 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.7677 -6.0009 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.0457 -5.5810 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.1834 -7.2422 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.6054 -4.7656 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.0455 -4.7561 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.4782 -5.5915 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.1920 -6.0071 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.9069 -5.5969 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.9089 -4.7711 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.1904 -4.3573 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.4787 -4.7700 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.6238 -4.3592 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.1849 -5.5914 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.4709 -6.0045 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.7561 -5.5926 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.0420 -6.0057 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.7554 -4.7677 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.3273 -5.5938 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2 3 1 0
10 13 2 0
3 6 2 0
1 2 2 0
14 15 2 0
5 4 2 0
15 16 1 0
4 1 1 0
16 17 2 0
5 10 1 0
17 18 1 0
6 7 1 0
18 19 2 0
19 14 1 0
9 14 1 0
7 8 1 0
17 20 1 0
8 9 2 0
1 21 1 0
9 10 1 0
21 22 1 0
5 6 1 0
22 23 2 0
2 11 1 0
23 24 1 0
23 25 1 0
4 12 1 0
24 26 1 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 354.36 | Molecular Weight (Monoisotopic): 354.1103 | AlogP: 3.06 | #Rotatable Bonds: 4 |
Polar Surface Area: 111.13 | Molecular Species: ACID | HBA: 6 | HBD: 4 |
#RO5 Violations: ┄ | HBA (Lipinski): 6 | HBD (Lipinski): 4 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 6.36 | CX Basic pKa: ┄ | CX LogP: 3.52 | CX LogD: 2.38 |
Aromatic Rings: 3 | Heavy Atoms: 26 | QED Weighted: 0.54 | Np Likeness Score: 2.01 |
References
1. Allen JG, Fotsch C, Babij P.. (2010) Emerging targets in osteoporosis disease modification., 53 (11): [PMID:20218623] [10.1021/jm9018756] |